Shaanxi Kanghui Pharm Co Ltd Working Capital to Net Assets Ratio
Shaanxi Kanghui Pharm Co Ltd working capital to net assets ratio. Shaanxi Kanghui Pharm Co Ltd (603139) has a Working Capital to Net Assets ratio of -56.6% as of March 2026. Working capital of CN¥-329.06 Million (current assets of CN¥555.27 Million minus current liabilities of CN¥884.33 Million) is measured against net assets of CN¥581.05 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Shaanxi Kanghui Pharm Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Shaanxi Kanghui Pharm Co Ltd (2012–2025)
Working capital to net assets ratio of Shaanxi Kanghui Pharm Co Ltd from 2012 to 2025. This chart shows how Shaanxi Kanghui Pharm Co Ltd's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at -56.6%, reflecting working capital of CN¥-329.06 Million against net assets of CN¥581.05 Million CNY. See 603139 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Shaanxi Kanghui Pharm Co Ltd Working Capital to Net Assets Ratio by Year (2012–2025)
Shaanxi Kanghui Pharm Co Ltd working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Shaanxi Kanghui Pharm Co Ltd from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Shaanxi Kanghui Pharm Co Ltd.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -59.9% | CN¥-340.60 Million | CN¥568.98 Million | CN¥589.90 Million | CN¥930.51 Million | ▼ -59.9 pp |
| 2024 | 0.1% | CN¥720.74K | CN¥906.90 Million | CN¥598.97 Million | CN¥598.25 Million | ▼ 0.0 pp |
| 2023 | 0.1% | CN¥1.31 Million | CN¥1.02 Billion | CN¥708.22 Million | CN¥706.92 Million | ▼ -21.2 pp |
| 2022 | 21.4% | CN¥219.21 Million | CN¥1.03 Billion | CN¥580.93 Million | CN¥361.72 Million | ▼ -9.9 pp |
| 2021 | 31.2% | CN¥348.17 Million | CN¥1.12 Billion | CN¥666.59 Million | CN¥318.42 Million | ▼ -2.0 pp |
| 2020 | 33.2% | CN¥356.49 Million | CN¥1.07 Billion | CN¥540.36 Million | CN¥183.87 Million | ▼ -37.0 pp |
| 2019 | 70.2% | CN¥713.68 Million | CN¥1.02 Billion | CN¥819.24 Million | CN¥105.56 Million | ▼ -10.5 pp |
| 2018 | 80.7% | CN¥790.35 Million | CN¥979.31 Million | CN¥911.03 Million | CN¥120.68 Million | ▼ -4.1 pp |
| 2017 | 84.8% | CN¥773.65 Million | CN¥912.11 Million | CN¥877.09 Million | CN¥103.44 Million | ▲ +10.7 pp |
| 2016 | 74.2% | CN¥387.70 Million | CN¥522.81 Million | CN¥517.05 Million | CN¥129.35 Million | ▲ +4.3 pp |
| 2015 | 69.9% | CN¥319.62 Million | CN¥457.58 Million | CN¥437.92 Million | CN¥118.29 Million | ▲ +4.0 pp |
| 2014 | 65.9% | CN¥260.53 Million | CN¥395.37 Million | CN¥370.14 Million | CN¥109.61 Million | ▲ +3.6 pp |
| 2013 | 62.3% | CN¥207.15 Million | CN¥332.63 Million | CN¥315.15 Million | CN¥107.99 Million | ▲ +1.3 pp |
| 2012 | 61.0% | CN¥128.29 Million | CN¥210.43 Million | CN¥232.31 Million | CN¥104.02 Million | — |